Dimensional Fund Advisors LP Meridian Bioscience Inc Transaction History

Dimensional Fund Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$31.15 - $33.39 $368,971 - $395,504	-11,845 Reduced 0.66%	1,791,282 $59.5 Million
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $4.05 Million - $4.39 Million	-130,964 Reduced 6.77%	1,803,127 $56.9 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $685,805 - $915,080	28,876 Added 1.52%	1,934,091 $58.8 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $376,075 - $507,334	18,832 Added 1.0%	1,905,215 $49.5 Million
Q4 2021 Feb 09, 2022	BUY	$17.46 - $21.61 $496,754 - $614,826	28,451 Added 1.53%	1,886,383 $38.5 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $614,589 - $797,017	35,423 Added 1.94%	1,857,932 $35.7 Million
Q2 2021 Aug 12, 2021	SELL	$18.01 - $28.32 $134,048 - $210,785	-7,443 Reduced 0.41%	1,822,509 $40.4 Million
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $1.32 Million - $1.99 Million	-66,615 Reduced 3.51%	1,829,952 $48 Million
Q4 2020 Feb 25, 2021	BUY	$15.73 - $21.66 $29.8 Million - $41.1 Million	1,896,567 New	1,896,567 $35.4 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.